Pier 88 Investment Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232 | Sell |
20
-200
| -91% | -$2.32K | ﹤0.01% | 105 |
|
|
2025
Q1 | $1.92K | Sell |
220
-10,260
| -98% | -$89.6K | ﹤0.01% | 101 |
|
|
2024
Q4 | $150K | Sell |
10,480
-2,300
| -18% | -$33K | 0.03% | 91 |
|
|
2024
Q3 | $289K | Sell |
12,780
-220
| -2% | -$4.97K | 0.06% | 84 |
|
|
2024
Q2 | $253K | Buy |
13,000
+5,900
| +83% | +$115K | 0.06% | 90 |
|
|
2024
Q1 | $266K | Buy |
7,100
+2,410
| +51% | +$90.4K | 0.07% | 83 |
|
|
2023
Q4 | $262K | Sell |
4,690
-5,000
| -52% | -$280K | 0.07% | 79 |
|
|
2023
Q3 | $400K | Hold |
9,690
| – | – | 0.1% | 80 |
|
|
2023
Q2 | $541K | Buy |
9,690
+5,500
| +131% | +$307K | 0.13% | 74 |
|
|
2023
Q1 | $234K | Hold |
4,190
| – | – | 0.06% | 80 |
|
|
2022
Q4 | $153K | Buy |
4,190
+1,680
| +67% | +$61.2K | 0.04% | 81 |
|
|
2022
Q3 | $71K | Sell |
2,510
-3,590
| -59% | -$102K | 0.02% | 95 |
|
|
2022
Q2 | $276K | Buy |
6,100
+3,760
| +161% | +$170K | 0.07% | 88 |
|
|
2022
Q1 | $178K | Sell |
2,340
-2,590
| -53% | -$197K | 0.06% | 80 |
|
|
2021
Q4 | $734K | Buy |
4,930
+3,900
| +379% | +$581K | 0.16% | 79 |
|
|
2021
Q3 | $150K | Sell |
1,030
-3,875
| -79% | -$564K | 0.05% | 107 |
|
|
2021
Q2 | $961K | Sell |
4,905
-1,240
| -20% | -$243K | 0.28% | 81 |
|
|
2021
Q1 | $1.11M | Sell |
6,145
-590
| -9% | -$107K | 0.38% | 58 |
|
|
2020
Q4 | $954K | Sell |
6,735
-995
| -13% | -$141K | 0.31% | 69 |
|
|
2020
Q3 | $964K | Buy |
7,730
+1,015
| +15% | +$127K | 0.29% | 72 |
|
|
2020
Q2 | $600K | Buy |
+6,715
| New | +$600K | 0.17% | 92 |
|